Morgan Stanley’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.6K Buy
18,853
+1,500
+9% +$1.16K ﹤0.01% 6749
2025
Q1
$9.54K Sell
17,353
-5,500
-24% -$3.03K ﹤0.01% 6814
2024
Q4
$20.9K Sell
22,853
-3,689
-14% -$3.37K ﹤0.01% 6560
2024
Q3
$23.1K Sell
26,542
-111,979
-81% -$97.5K ﹤0.01% 6460
2024
Q2
$137K Sell
138,521
-209,792
-60% -$208K ﹤0.01% 5844
2024
Q1
$369K Sell
348,313
-114,457
-25% -$121K ﹤0.01% 5450
2023
Q4
$625K Buy
462,770
+400,276
+641% +$540K ﹤0.01% 5528
2023
Q3
$136K Sell
62,494
-121,719
-66% -$265K ﹤0.01% 5741
2023
Q2
$479K Buy
184,213
+77,228
+72% +$201K ﹤0.01% 5236
2023
Q1
$128K Buy
106,985
+2,775
+3% +$3.33K ﹤0.01% 5912
2022
Q4
$170K Buy
104,210
+5,732
+6% +$9.34K ﹤0.01% 5738
2022
Q3
$121K Buy
98,478
+6,587
+7% +$8.09K ﹤0.01% 5983
2022
Q2
$93K Buy
91,891
+32,526
+55% +$32.9K ﹤0.01% 6313
2022
Q1
$94K Sell
59,365
-28,185
-32% -$44.6K ﹤0.01% 6351
2021
Q4
$122K Buy
87,550
+4,398
+5% +$6.13K ﹤0.01% 6321
2021
Q3
$174K Buy
83,152
+36,874
+80% +$77.2K ﹤0.01% 6073
2021
Q2
$128K Sell
46,278
-4,700
-9% -$13K ﹤0.01% 6235
2021
Q1
$194K Buy
50,978
+13,431
+36% +$51.1K ﹤0.01% 5675
2020
Q4
$90K Buy
37,547
+14,270
+61% +$34.2K ﹤0.01% 5956
2020
Q3
$40K Buy
23,277
+4,448
+24% +$7.64K ﹤0.01% 5801
2020
Q2
$35K Buy
18,829
+15,117
+407% +$28.1K ﹤0.01% 5807
2020
Q1
$5K Sell
3,712
-136,566
-97% -$184K ﹤0.01% 6217
2019
Q4
$668K Sell
140,278
-62,731
-31% -$299K ﹤0.01% 4764
2019
Q3
$115K Buy
203,009
+146,549
+260% +$83K ﹤0.01% 5392
2019
Q2
$97K Buy
56,460
+8,476
+18% +$14.6K ﹤0.01% 5339
2019
Q1
$89K Sell
47,984
-5,100
-10% -$9.46K ﹤0.01% 5438
2018
Q4
$96K Sell
53,084
-260
-0.5% -$470 ﹤0.01% 5574
2018
Q3
$206K Buy
53,344
+6,362
+14% +$24.6K ﹤0.01% 5446
2018
Q2
$258K Buy
+46,982
New +$258K ﹤0.01% 5443